drugset / Trial / NCT01755572
Blood Pressure Outcomes With Liraglutide Therapy
RandomizedCrossoverTriple-blindBasic science
Summary
Purpose: The purpose of this study is to further study the mechanism by which liraglutide, a relatively new anti-hyperglycemic medication, might lower blood pressure in patients with Type 2 diabetes and high blood pressure.
Timeline
- Start
- 2013-01
- Primary completion
- 2014-01
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 1.8 mg | — |